LabCompass

Steven Ing

Medicine · The Ohio State University

Mid career · publishing since 2003Rising activity

Publications

82

Citations

1,216

Est. group size

Recurring co-author estimate

Active years

24

Publishing since 2003

Research summary
AI-generated

Steven Ing's research focuses on metabolic bone and mineral disorders, particularly hypoparathyroidism and hypophosphatasia, two conditions affecting calcium and bone metabolism. His work includes clinical trials of hormone-replacement therapies, patient-reported outcome measures, disease registries, and diagnostic criteria development, as well as broader studies on osteoporosis and bone density in different patient populations.

Hypoparathyroidism treatment and outcomesHypophosphatasia diagnosis and disease burdenOsteoporosis and bone mineral densityParathyroid hormone therapiesPatient-reported outcomes in bone/endocrine disease

Publication output has grown over the last decade, rising from about 4 papers per year in 2017 to a peak of 13 in 2024, with an average of roughly 7 per year over the last five years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 7.2/year recently
2017: 4 publications172018: 3 publications182019: 6 publications192020: 5 publications202021: 8 publications212022: 7 publications222023: 8 publications232024: 13 publications13242025: 6 publications252026: 2 publications26
Recent publications
Publishes in
  • Journal of the Endocrine Society×11
  • JBMR Plus×6
  • Osteoporosis International×4
  • Journal of Bone and Mineral Research×4
  • Endocrine Practice×3
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile